Oncol Lett 2016 Apr 10;11(4):2520-2524. Epub 2016 Feb 10.
Department of Radiology, University of Tokyo Hospital, Tokyo 113-0033, Japan.
|PDF Download - Full Text Link
( Please be advised that this article is hosted on an external website not affiliated with PubFacts.com)
Cancer 2005 Aug;104(4):856-63
Department of Radiation Oncology, Institut Curie, Paris, France.
Background: Sarcomas are a rare complication of radiotherapy for breast carcinoma and patients have a poor prognosis. The incidence, histology, and management of patients with sarcomas were reviewed in the current study.
Methods: The authors reviewed the records of 16,705 patients with breast carcinoma. Read More
Surg Case Rep 2015 7;1(1):76. Epub 2015 Sep 7.
Breast Center, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido 078-8510 Japan.
Background: Radiation therapy (RT) is considered a risk factor for the development of sarcoma in patients with breast cancer. However, there are few reports regarding post-irradiation sarcoma (PIS).
Case Presentation: The patient was a 59-year-old woman who presented with a chief complaint of induration in the lower outer quadrant of the left breast. Read More
Neuropathology 2018 Jun 3;38(3):309-314. Epub 2018 Jan 3.
Department of Laboratory Medicine and Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA.
We report a case of low-grade fibromyxoid sarcoma arising within the median nerve. A 31-year-old woman presented with symptoms of carpal tunnel syndrome and an enlarging mass in her right palm over 1 year. MRI demonstrated a mass associated with the right median nerve with solid and cystic components. Read More
J Clin Oncol 1998 Nov;16(11):3528-36
Department of Radiation Oncology, Massachusetts General Hospital, Boston 02114, USA.
Purpose: An improvement in radiation dose schedule is necessary to increase local tumor control and survival in limited-stage small-cell lung cancer. The goal of this study was to determine the maximum-tolerated dose (MTD) of radiation (RT) in both standard daily and hyperfractionated-accelerated (HA) twice-daily RT schedules in concurrent chemoradiation.
Methods: The study design consisted of a sequential dose escalation in both daily and HA twice-daily RT regimens. Read More